II 

Calendar No. 351 

112TH CONGRESS 

2D SESSION S. 2159 

To extend the authorization of the Drug-Free Communities Support Program 

through fiscal year 2017. 

IN THE SENATE OF THE UNITED STATES 

MARCH 6, 2012 

Mr. LEAHY (for himself, Mr. GRASSLEY, Mrs. FEINSTEIN, Mr. PORTMAN, Mr. 

SCHUMER, Ms. KLOBUCHAR, and Mr. KOHL) introduced the following 

bill; which was read twice and referred to the Committee on the Judiciary 

MARCH 29, 2012 

Reported by Mr. LEAHY, with an amendment 

[Strike out all after the enacting clause and insert the part printed in italic] 

A BILL 

To extend the authorization of the Drug-Free Communities 

Support Program through fiscal year 2017. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


jbell on DSK7SPTVN1PROD with BILLS
2 

•S 2159 RS

1 SECTION 1. EXTENSION OF THE DRUG-FREE COMMUNITIES 

2 SUPPORT PROGRAM THROUGH FISCAL YEAR 

3 2017. 

4 Section 1024(a) of the National Narcotics Leadership 

5 Act of 1988 (21 U.S.C. 1524(a)) is amended by striking 

6 paragraph (9) and all that follows and inserting the fol7 lowing: 

8 ‘‘(9) $90,000,000 for fiscal year 2006; 

9 ‘‘(10) $99,000,000 for fiscal year 2007; 

10 ‘‘(11) $109,000,000 for fiscal year 2008; 

11 ‘‘(12) $114,000,000 for fiscal year 2009; 

12 ‘‘(13) $119,000,000 for fiscal year 2010; 

13 ‘‘(14) $124,000,000 for fiscal year 2011; 

14 ‘‘(15) $129,000,000 for fiscal year 2012; 

15 ‘‘(16) $100,000,000 for fiscal year 2013; 

16 ‘‘(17) $100,000,000 for fiscal year 2014; 

17 ‘‘(18) $100,000,000 for fiscal year 2015; 

18 ‘‘(19) $100,000,000 for fiscal year 2016; and 

19 ‘‘(20) $100,000,000 for fiscal year 2017.’’. 

20 SECTION 1. EXTENSION OF THE DRUG-FREE COMMUNITIES 

21 SUPPORT PROGRAM THROUGH FISCAL YEAR 

22 2017. 

23 Section 1024(a) of the National Narcotics Leadership 

24 Act of 1988 (21 U.S.C. 1524(a)) is amended by striking 

25 paragraph (9) and all that follows and inserting the fol26 lowing: 


jbell on DSK7SPTVN1PROD with BILLS
3 

•S 2159 RS

1 ‘‘(9) $90,000,000 for fiscal year 2006; 

2 ‘‘(10) $99,000,000 for fiscal year 2007; 

3 ‘‘(11) $109,000,000 for fiscal year 2008; 

4 ‘‘(12) $114,000,000 for fiscal year 2009; 

5 ‘‘(13) $119,000,000 for fiscal year 2010; 

6 ‘‘(14) $124,000,000 for fiscal year 2011; 

7 ‘‘(15) $129,000,000 for fiscal year 2012; 

8 ‘‘(16) $100,000,000 for fiscal year 2013; 

9 ‘‘(17) $100,000,000 for fiscal year 2014; 

10 ‘‘(18) $100,000,000 for fiscal year 2015; 

11 ‘‘(19) $100,000,000 for fiscal year 2016; and 

12 ‘‘(20) $100,000,000 for fiscal year 2017.’’. 

13 SEC. 2. OVERSIGHT OF OTHER AGENCY ADMINISTERING 

14 DRUG-FREE COMMUNITIES SUPPORT PRO15 GRAM. 

16 Section 1031 of the National Narcotics Leadership Act 

17 of 1988 (21 U.S.C. 1531) is amended— 

18 (1) in subsection (b)— 

19 (A) in paragraph (2), by striking ‘‘and’’ at 

20 the end; 

21 (B) in paragraph (3), by striking the period 

22 at the end and inserting ‘‘; and’’; and 

23 (C) by adding at the end the following: 

24 ‘‘(4) ensure that— 


jbell on DSK7SPTVN1PROD with BILLS
4 

•S 2159 RS

1 ‘‘(A) each recipient of an initial grant or a 

2 renewal grant meets the grant eligibility criteria 

3 under section 1032(a) for each fiscal year; and 

4 ‘‘(B) the meeting of the grant eligibility cri5 teria under section 1032(a) for each fiscal year 

6 by each recipient of an initial grant or a re7 newal grant is fully documented.’’; and 

8 (2) in subsection (d)— 

9 (A) by striking ‘‘The Director’’ and insert10 ing the following: ‘‘(1) IN GENERAL.—The Direc11 tor’’; and 

12 (B) by adding at the end the following: 

13 ‘‘(2) OVERSIGHT OF OTHER AGENCY ADMIN14 ISTERING PROGRAM.—If the Director enters into an 

15 agreement under paragraph (1) to delegate authority 

16 to the Substance Abuse and Mental Health Services 

17 Administration, the Director shall— 

18 ‘‘(A) develop and document an approach to 

19 monitoring and overseeing the administration of 

20 the Program by the Substance Abuse and Mental 

21 Health Services Administration; and 

22 ‘‘(B) fully define in the agreement prepared 

23 for each fiscal year between the Director and the 

24 Substance Abuse and Mental Health Services Ad25 ministration the respective roles and responsibilVerDate Mar 15 2010 23:48 Mar 29, 2012 Jkt 099200 PO 00000 Frm 00004 Fmt 6652 Sfmt 6203 E:\BILLS\S2159.RS S2159

jbell on DSK7SPTVN1PROD with BILLS
5 

•S 2159 RS

1 ities, with respect to administering the Program, 

2 of— 

3 ‘‘(i) the Office of National Drug Con4 trol Policy, including the role and respon5 sibilities of the Administrator; and 

6 ‘‘(ii) the Substance Abuse and Mental 

7 Health Services Administration.’’. 

8 SEC. 3. NATIONAL COMMUNITY ANTI-DRUG COALITION IN9 STITUTE. 

10 Subchapter I of chapter 2 of the National Narcotics 

11 Leadership Act of 1988 (21 U.S.C. 1531 et seq.) is amended 

12 by adding at the end the following: 

13 ‘‘SEC. 1036. NATIONAL COMMUNITY ANTI-DRUG COALITION 

14 INSTITUTE. 

15 ‘‘(a) IN GENERAL.—The Director may, using amounts 

16 authorized to be appropriated by subsection (d), make a 

17 grant to an eligible organization to provide for the estab18 lishment of a National Community Anti-Drug Coalition 

19 Institute. 

20 ‘‘(b) ELIGIBLE ORGANIZATIONS.—An organization eli21 gible for the grant under subsection (a) is any national non22 profit organization that represents, provides technical as23 sistance and training to, and has special expertise and 

24 broad, national-level experience in community anti-drug 

25 coalitions under section 1032. 


jbell on DSK7SPTVN1PROD with BILLS
6 

•S 2159 RS

1 ‘‘(c) USE OF GRANT AMOUNT.—The organization re2 ceiving the grant under subsection (a) shall establish a Na3 tional Community Anti-Drug Coalition Institute to— 

4 ‘‘(1) provide education, training, and technical 

5 assistance for coalition leaders and community teams, 

6 with emphasis on the development of coalitions serv7 ing economically disadvantaged areas; 

8 ‘‘(2) develop and disseminate evaluation tools, 

9 mechanisms, and measures to better assess and docu10 ment coalition performance measures and outcomes; 

11 and 

12 ‘‘(3) bridge the gap between research and prac13 tice by translating knowledge from research into prac14 tical information. 

15 ‘‘(d) AUTHORIZATION OF APPROPRIATIONS.—There is 

16 authorized to be appropriated for purposes of activities 

17 under this section, including the grant under subsection (a), 

18 $2,000,000 for each of fiscal years 2013 through 2017.’’. 


jbell on DSK7SPTVN1PROD with BILLS

jbell on DSK7SPTVN1PROD with BILLS
Calendar No. 351 

112TH CONGRESS 

2D SESSION S. 2159 

A BILL 

To extend the authorization of the Drug-Free Com2017. munities Support Program through fiscal year 

MARCH 29, 2012 

Reported with an amendment 


jbell on DSK7SPTVN1PROD with BILLS